Cochrane Database Syst Rev 2021;4:CD004407
Swiss Pharmaceuticals BPC-157 60 Caps , ,
The 0.9% benzyl alcohol preservative concentration is the established pharmaceutical standard providing effective bacteriostasis across the relevant microbial challenge spectrum while remaining compatible with the chemical stability requirements of the peptide and protein research compounds reconstituted within it
It's a naturally occurring copper-binding peptide that directly stimulates collagen I, collagen III, and elastin synthesis the structural proteins that make up the annulus fibrosus
Notably, newborn infants are at risk of severe toxicity (as discussed in Contraindications), but in adults and older children, the small benzyl alcohol dose is very well tolerated
In this case study, our patient presented with tachypnea, jaundice, intractable metabolic acidosis, and hemolytic anemia